Key result
Heparin-releasable lipoprotein-associated coagulation inhibitor was purified 185,000-fold with a 33% yield and shown to be structurally different from lipoprotein LACI.
Heparin-releasable LACI is structurally distinct from lipoprotein LACI and has a slower clearance rate in vivo, suggesting association with vascular endothelium.
Answers are grounded in this paper and cite their sources.
Animal data distinguish heparin-releasable LACI; leaves open its endothelial role and human relevance.
The lipoprotein-associated coagulation inhibitor (LACI) is present in vivo in at least three different pools: sequestered in platelets, associated with plasma lipoproteins, and released into plasma by intravenous heparin, possibly from vascular endothelium. In this study we have purified the heparin-relesable form of LACI from post-heparin plasma and show that it is structurally different from lipoprotein LACI. The purification scheme uses heparin-agarose chromatography, immunoaffinity chromatography, and size-exclusion chromatography and results in a 185,000-fold purification with a 33% yield. Heparin- releasable LACI (HRL), as analyzed by sodium dodecyl sulfate- polyacrylamide gel electrophoresis, under reducing conditions, appears as a major band at 40 Kd and a minor band at 36 Kd. Immunoblot analysis suggests that the 36-Kd band arises from carboxyl-terminus proteolysis that occurs during the purification. HRL has a specific activity similar to that of HepG2 or lipoprotein LACI. HRL and lipoprotein LACI combine with lipoproteins in vitro while purified HepG2 LACI does not. I125-labeled HRL, injected into a rabbit, is cleared more slowly than I125-labeled HepG2 LACI, which may be due to attachment to lipoproteins in vivo. Preliminary evidence suggests that HRL is associated with vascular endothelium, possibly by attachment to glycosaminoglycans.
No takes yet. Share an insight, caveat, or question.
Novotny et al. (1991) studied this question. Heparin-releasable LACI (HRL) purification vs. Lipoprotein LACI / HepG2 LACI was evaluated on Purification yield and structural properties. Heparin-releasable lipoprotein-associated coagulation inhibitor was purified 185,000-fold with a 33% yield and shown to be structurally different from lipoprotein LACI.
Synapse has enriched 10 related papers. Consider them for comparative context: